Eosinophilia-myalgia syndrome (EMS) in Canada.
Wilkins
K
K
Surveillance and Risk Assessment Division, Bureau of Chronic Disease Epidemiology, Ottawa, Ontario.
Wigle
D
D
D002170:Canada / Q000453:epidemiology; D004802:Eosinophilia / Q000139:chemically induced* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced* / Q000453:epidemiology; D013577:Syndrome; D014364:Tryptophan / Q000009:adverse effects*
D014364:Tryptophan